Fisher revised scale for assessment of prognosis in patients with subarachnoid hemorrhage

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVEIRA, Arthur Maynart Pereira
dc.contributor.authorPAIVA, Wellingson Silva
dc.contributor.authorFIGUEIREDO, Eberval Gadelha de
dc.contributor.authorOLIVEIRA, Hello Araujo
dc.contributor.authorTEIXEIRA, Manoel Jacobsen
dc.date.accessioned2017-11-27T16:28:53Z
dc.date.available2017-11-27T16:28:53Z
dc.date.issued2011
dc.description.abstractThe Fisher revised scale (FRS) presents an alternative for evaluating patients with subarachnoid hemorrhage (SAH). In this study, we compared the prognosis of patients with SAH and vasospasms (VSP). Method: This was a prospective study on patients with a diagnosis of aneurysmal SAH, 72 hours after the initial event. Sequential neurological examinations and Hunt and Hess (HaH) score were performed on the 1(st), 7(th) and 14(th) days. Transcranial Doppler was used to assess vasospasms. Results: Out of the 24 patients studied, ten (41.66%) presented a delayed neurological deficit, such as diminished consciousness, decreased HaH score or death. The single patient classified as FS-1 did not have any delayed neurological deficit, while such deficits evolved in one patient out of five with FS-2 (20%); two out of seven with FS-3 (28.57%) and seven out of 11 with FS-4 (63.63%). Conclusion: Level three of the FS and FRS seemed to be compatible with regard to predicting the likelihood of progression to severe VSP.
dc.description.abstractA escala revisada de Fisher (FRS) representa uma alternativa para avaliação de pacientes com hemorragia subaracnóidea (HSA). Neste estudo comparamos a evolução prognóstica referente ao vasoespasmo (VSP) nos pacientes com HSA. MÉTODO: Estudo prospectivo em pacientes com diagnóstico de HSA, com 72 horas após o evento inicial. Escala de Hunt e Hess (HeH) foi realizada no 1º, 7º, 14º dia. Utilizamos Doppler transcraniano para avaliação de VSP. RESULTADOS: Dos 24 pacientes estudados dez (41,66%) tiveram déficit neurológico tardio (DNT), como diminuição da consciência, grau de HeH ou morte. Um paciente de cinco classificados como FS-2 (20%), dois de sete pacientes com FS-3 (28,57%) e sete de 11 pacientes com FS-4 (63,63%) evoluíram com DNT. Para o FRS não encontramos piora neurológica precoce no paciente com FRS-0. CONCLUSÃO: O nível três da FS e FRS parecem ser comparáveis, quando se trata de predizer a probabilidade de progressão para VSP grave.
dc.description.indexMEDLINE
dc.identifier.citationARQUIVOS DE NEURO-PSIQUIATRIA, v.69, n.6, p.910-913, 2011
dc.identifier.issn0004-282X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/23105
dc.language.isoeng
dc.publisherASSOC ARQUIVOS NEURO- PSIQUIATRIA
dc.relation.ispartofArquivos de Neuro-Psiquiatria
dc.rightsopenAccess
dc.rights.holderCopyright ASSOC ARQUIVOS NEURO- PSIQUIATRIA
dc.subjectsubarachnoid hemorrhage
dc.subjectintracranial vasospasm
dc.subjectprognosis
dc.subjecthemorragia subaracnóidea
dc.subjectvasoespasmo intracraniano
dc.subjectprognóstico
dc.subject.otherdelayed cerebral-ischemia
dc.subject.othervasospasm
dc.subject.otherblood
dc.subject.otherrisk
dc.subject.wosNeurosciences
dc.subject.wosPsychiatry
dc.titleFisher revised scale for assessment of prognosis in patients with subarachnoid hemorrhage
dc.title.alternativeAvaliação prognóstica com escala de Fisher modificada em pacientes com hemorragia subaracnóidea
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalOLIVEIRA, Arthur Maynart Pereira:Univ Sao Paulo, Med Sch HC FMUSP, Dept Neurol, Div Neurosurg,Hosp Clin, Sao Paulo, Brazil
hcfmusp.author.externalOLIVEIRA, Hello Araujo:Univ Fed Sergipe, Div Neurol, Aracaju, SE, Brazil
hcfmusp.citation.scopus8
hcfmusp.contributor.author-fmusphcWELLINGSON SILVA PAIVA
hcfmusp.contributor.author-fmusphcEBERVAL GADELHA FIGUEIREDO
hcfmusp.contributor.author-fmusphcMANOEL JACOBSEN TEIXEIRA
hcfmusp.description.beginpage910
hcfmusp.description.endpage913
hcfmusp.description.issue6
hcfmusp.description.volume69
hcfmusp.origemWOS
hcfmusp.origem.pubmed22297878
hcfmusp.origem.scopus2-s2.0-84868294063
hcfmusp.origem.wosWOS:000298019300012
hcfmusp.publisher.citySAO PAULO SP
hcfmusp.publisher.countryBRAZIL
hcfmusp.relation.referenceHIJDRA A, 1988, STROKE, V19, P1250
hcfmusp.relation.referenceClaassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677
hcfmusp.relation.referenceQureshi AI, 2000, CRIT CARE MED, V28, P984, DOI 10.1097/00003246-200004000-00012
hcfmusp.relation.referenceBROUWERS PJAM, 1993, STROKE, V24, P809
hcfmusp.relation.referenceWEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173
hcfmusp.relation.referenceFISHER CM, 1980, NEUROSURGERY, V6, P1
hcfmusp.relation.referenceKISTLER JP, 1983, NEUROLOGY, V33, P424
hcfmusp.relation.referenceVermeij FH, 1998, STROKE, V29, P924
hcfmusp.relation.referenceBRODERICK JP, 1989, STROKE, V20, P577
hcfmusp.relation.referenceAzevedo-Filho HR, 2009, ESSENTIAL PRACTICE N, P734
hcfmusp.relation.referenceHop JW, 1999, STROKE, V33, P424
hcfmusp.relation.referenceMosten F, 1984, J NEUROL NEUROSUR PS, V47, P1197
hcfmusp.relation.referenceMurayama Y, 1997, J NEUROSURG, V87, P830, DOI 10.3171/jns.1997.87.6.0830
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationb0c9118e-a4e8-4a25-91f1-ed0445ced2bd
relation.isAuthorOfPublicationb4a34dbe-d274-4cdd-8485-5c8e561da3a4
relation.isAuthorOfPublicationb665cf91-624e-4b90-92bc-9df755eeeaaf
relation.isAuthorOfPublication.latestForDiscoveryb0c9118e-a4e8-4a25-91f1-ed0445ced2bd
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_OLIVEIRA_Fisher_revised_scale_for_assessment_of_prognosis_in_2011.PDF
Tamanho:
1.3 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (Portuguese)